Regulatory PathRegulatory requirements compared

Active substance

Prazosin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
MINIPRESS TAB 1MG1 mgTablet · Oral use100 BlisterSAR 22.95NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIPRESS TAB 1MG1 mgTablet · Oral use30 BlisterSAR 11.95NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIPRESS TAB 2MG2 mgTablet · Oral use100 BlisterSAR 38.35NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIPRESS TAB 2MG2 mgTablet · Oral use30 BlisterSAR 19.90NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIPRESS TAB 5MG5 mgTablet · Oral use100 BlisterSAR 67.55NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIPRESS TAB 5MG5 mgTablet · Oral use30 BlisterSAR 22.80NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
MINIPRESSEQ 5MG BASE; EQ 1MG BASE; EQ 2MG BASEcapsule · oralPFIZERPrescription23 Jun 1976
PRAZOSIN HYDROCHLORIDEEQ 5MG BASE; EQ 1MG BASE; EQ 2MG BASEcapsule · oralTEVA PHARMSPrescription12 Sep 1988
PRAZOSIN HYDROCHLORIDEEQ 1MG BASEcapsule · oralIVAX SUB TEVA PHARMSPrescription12 Sep 1988
PRAZOSIN HYDROCHLORIDEEQ 2MG BASEcapsule · oralTEVA PHARMSPrescription12 Sep 1988
PRAZOSIN HYDROCHLORIDEEQ 1MG BASEcapsule · oralMYLANPrescription28 Feb 1989
PRAZOSIN HYDROCHLORIDEEQ 2MG BASEcapsule · oralMYLANPrescription28 Feb 1989
PRAZOSIN HYDROCHLORIDEEQ 5MG BASE; EQ 2MG BASE; EQ 1MG BASEcapsule · oralMYLANPrescription28 Feb 1989
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralNOVITIUM PHARMAPrescription3 Oct 2018
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralGRANULESPrescription23 Dec 2021
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralAPPCOPrescription21 Oct 2022
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralMANKIND PHARMAPrescription30 Dec 2022
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralALEMBICPrescription6 Mar 2023
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralAUROBINDO PHARMA LTDPrescription31 Mar 2023
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralMSNPrescription17 Sep 2024
PRAZOSIN HYDROCHLORIDEEQ 2MG BASEcapsule · oralWATSON LABSDiscontinued11 Jan 1989
PRAZOSIN HYDROCHLORIDEEQ 1MG BASEcapsule · oralWATSON LABSDiscontinued11 Jan 1989
PRAZOSIN HYDROCHLORIDEEQ 5MG BASEcapsule · oralWATSON LABSDiscontinued11 Jan 1989
PRAZOSIN HYDROCHLORIDEEQ 1MG BASEcapsule · oralDAVA PHARMS INCDiscontinued15 Mar 1989
PRAZOSIN HYDROCHLORIDEEQ 2MG BASEcapsule · oralDAVA PHARMS INCDiscontinued15 Mar 1989
PRAZOSIN HYDROCHLORIDEEQ 5MG BASEcapsule · oralDAVA PHARMS INCDiscontinued15 Mar 1989
PRAZOSIN HYDROCHLORIDEEQ 2MG BASE; EQ 1MG BASE; EQ 5MG BASEcapsule · oralANI PHARMSDiscontinued10 Apr 1989
MINIPRESS XL2.5MG; 5MGtablet, extended release · oralPFIZERDiscontinued29 Jan 1992
PRAZOSIN HYDROCHLORIDEEQ 1MG BASE; EQ 2MG BASE; EQ 5MG BASEcapsule · oralLANNETT CO INCDiscontinued3 Jan 2024
PRAZOSIN HYDROCHLORIDEEQ 1MG BASEcapsule · oralAM THERAPDiscontinued
PRAZOSIN HYDROCHLORIDEEQ 2MG BASEcapsule · oralAM THERAPDiscontinued

4 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO-PRAZO008828011 MGTABLET · ORALAPOTEX INC
APO-PRAZO008828282 MGTABLET · ORALAPOTEX INC
APO-PRAZO008828365 MGTABLET · ORALAPOTEX INC
TEVA-PRAZOSIN019341981 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-PRAZOSIN019342012 MGTABLET · ORALTEVA CANADA LIMITED
TEVA-PRAZOSIN019342285 MGTABLET · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACPRAZOSIN 1 MG CAPSULE$0.08417per EA23 Sep 2026
US NADACPRAZOSIN 2 MG CAPSULE$0.08634per EA23 Sep 2026
US NADACPRAZOSIN 5 MG CAPSULE$0.13371per EA23 Sep 2026
NHS Drug TariffPrazosin 500microgram tablets£2.6960 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.